Access to oxytocin and misoprostol for management of postpartum haemorrhage in Kenya, Uganda and Zambia: a cross-sectional assessment of availability, prices and affordability
- PMID: 33414148
- PMCID: PMC7797249
- DOI: 10.1136/bmjopen-2020-042948
Access to oxytocin and misoprostol for management of postpartum haemorrhage in Kenya, Uganda and Zambia: a cross-sectional assessment of availability, prices and affordability
Abstract
Objective: To assess access (availability and affordability) to oxytocin and misoprostol at health facilities in Kenya, Uganda and Zambia to improve prevention and management of postpartum haemorrhage (PPH).
Design: The assessment was undertaken using data from Health Action International (HAI) research on sexual and reproductive health commodities based on a cross-sectional design adapted from the standardised WHO/HAI methodology.
Setting: Data were collected from 376 health facilities in in Kenya, Uganda and Zambia in July and August 2017.
Outcome measures: Availability was calculated as mean percentage of sampled medicine outlets where medicine was found on the day of data collection. Medicine prices were compared with international reference prices (IRP) and expressed as median price ratios. Affordability was calculated using number of days required to pay for a standard treatment based on the daily income of the lowest paid government worker.
Results: Availability of either oxytocin or misoprostol at health facilities was high; 81% in Kenya, 82% in Uganda and 76% in Zambia. Oxytocin was more available than misoprostol, and it was most available in the public sector in the three countries. Availability of misoprostol was highest in the public sector in Uganda (88%). Oxytocin and misoprostol were purchased by patients at prices above IRP, but both medicines cost less than a day's wages and were therefore affordable. Availability of misoprostol was poor in rural settings where it would be more preferred due to lack of trained personnel and cold storage facilities required for oxytocin.
Conclusion: Availability and affordability of either oxytocin or misoprostol at health facilities met the WHO benchmark of 80%. However, countries with limited resources should explore mechanisms to optimise management of PPH by improving access to misoprostol especially in rural areas.
Keywords: health policy; maternal medicine; reproductive medicine.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Access to sexual and reproductive health commodities in East and Southern Africa: a cross-country comparison of availability, affordability and stock-outs in Kenya, Tanzania, Uganda and Zambia.BMC Public Health. 2020 Jul 3;20(1):1053. doi: 10.1186/s12889-020-09155-w. BMC Public Health. 2020. PMID: 32620159 Free PMC article.
-
Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.PLoS One. 2019 Apr 25;14(4):e0216122. doi: 10.1371/journal.pone.0216122. eCollection 2019. PLoS One. 2019. PMID: 31022276 Free PMC article.
-
Trends in access to anti-malarial treatment in the formal private sector in Uganda: an assessment of availability and affordability of first-line anti-malarials and diagnostics between 2007 and 2018.Malar J. 2021 Mar 10;20(1):142. doi: 10.1186/s12936-021-03680-8. Malar J. 2021. PMID: 33691704 Free PMC article.
-
A systematic scoping review of medicine availability and affordability in Africa.BMC Health Serv Res. 2024 Jan 17;24(1):91. doi: 10.1186/s12913-023-10494-8. BMC Health Serv Res. 2024. PMID: 38233851 Free PMC article.
-
Health System Capacity and Access Barriers to Diagnosis and Treatment of CVD and Diabetes in Nepal.Glob Heart. 2021 May 18;16(1):38. doi: 10.5334/gh.927. Glob Heart. 2021. PMID: 34040951 Free PMC article.
Cited by
-
Quality of care for postpartum hemorrhage: A direct observation study in referral hospitals in Kenya.PLOS Glob Public Health. 2023 Mar 2;3(3):e0001670. doi: 10.1371/journal.pgph.0001670. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 36963063 Free PMC article.
-
Misoprostol Versus Oxytocin for the Prevention of Postpartum Haemorrhage: A Systematic Review and Meta-Analysis Including Individual Participant Data.BJOG. 2025 Sep;132(10):1364-1377. doi: 10.1111/1471-0528.18197. Epub 2025 May 13. BJOG. 2025. PMID: 40357798 Free PMC article. Review.
-
Enhancing maternal health in Zambia: a comprehensive approach to addressing postpartum hemorrhage.Front Glob Womens Health. 2024 Aug 6;5:1362894. doi: 10.3389/fgwh.2024.1362894. eCollection 2024. Front Glob Womens Health. 2024. PMID: 39165380 Free PMC article. No abstract available.
References
-
- World Health Organization Trends in maternal mortality: 2000 to 2017: estimates by who, UNICEF, UNFPA, world bank group and the United nations population division. Geneva: World Health Organization, 2019.
-
- PSI Improving maternal health: preventing post-partum hemorrhage in Rural Zambia. Washington D.C: PSI, 2014.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous